tirzepatide para que sirve efectos secundarios Qué es la tirzepatida, el nuevo fármaco tratar la diabetes tipo 2 y la obesidad aprobado por el ISP en Chile Efectos secundarios de la tirzepatida

The organoids accurately recapitulate the original ECs subtype, and show (and maintain) the tumors genotype and mutational profile

Reserva ya

Key points: In the only head-to-head trial, Wegovy produced 15.8% weight loss compared with 6.4% for Saxenda over the same 68-week period Wegovy 7.2 mg (approved January 2026) produces even greater results at 20.7% average weight loss Real-world data from Second Nature shows 19.1% weight loss with semaglutide when combined with behavioural support Semaglutide participants were nearly three times more likely to achieve at least 10% weight loss than liraglutide participants Side effects and tolerability Both medications share a similar side-effect profile, predominantly affecting the gastrointestinal tract

However, the researchers noted that statistically significant effects were weak and in part could be due to incidental change in the placebo group

A medically guided switching protocol is crucial for safely and effectively transitioning between weight loss medications